Payment overview · 2025
General Payments
$32.77
2 reported records · 2 companies
Healthcare provider profile · identity verified
Michael Jonathan Crooks, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · KALAMAZOO, MI · NPI 1447293469
Verified facts
What the public records show
CMS Open Payments records show Michael Jonathan Crooks, M.D. received $32.77 in general payments during 2025 across 2 reported records.
Abbott Laboratories accounted for 58.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $19.01 | 58.0% | 1 | 2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | Unresolved — no canonical attribution shown | $13.76 | 42.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.01 | 1 |
| Education | $13.76 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $19.01 | 1 | 2025 |
Source payment records
|
|||||
| EOHILIA Normalized: eohilia |
Drug | Takeda Pharmaceuticals U.S.A., Inc. | $13.76 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 692 | 192 |
| Atorvastatin Calcium | Atorvastatin Calcium | 678 | 194 |
| Amlodipine Besylate | Amlodipine Besylate | 518 | 144 |
| Omeprazole | Omeprazole | 377 | 115 |
| Alprazolam | Alprazolam | 358 | 82 |
| Lisinopril | Lisinopril | 334 | 100 |
| Simvastatin | Simvastatin | 288 | 77 |
| Metoprolol Succinate | Metoprolol Succinate | 281 | 81 |
| Tamsulosin Hcl | Tamsulosin Hcl | 277 | 76 |
| Gabapentin | Gabapentin | 265 | 72 |
| Eliquis | Apixaban | 243 | 70 |
| Meloxicam | Meloxicam | 220 | 77 |
| Losartan Potassium | Losartan Potassium | 211 | 64 |
| Prednisone | Prednisone | 200 | 128 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 194 | 37 |
| Zolpidem Tartrate | Zolpidem Tartrate | 187 | 48 |
| Hydrochlorothiazide | Hydrochlorothiazide | 180 | 56 |
| Metformin Hcl | Metformin Hcl | 180 | 53 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 172 | 56 |
| Furosemide | Furosemide | 158 | 52 |
| Sertraline Hcl | Sertraline Hcl | 157 | 42 |
| Escitalopram Oxalate | Escitalopram Oxalate | 147 | 48 |
| Pantoprazole Sodium | Pantoprazole Sodium | 144 | 45 |
| Potassium Chloride | Potassium Chloride | 129 | 35 |
| Fluticasone Propionate | Fluticasone Propionate | 127 | 47 |
| Montelukast Sodium | Montelukast Sodium | 125 | 43 |
| Atenolol | Atenolol | 124 | 34 |
| Citalopram Hbr | Citalopram Hydrobromide | 122 | 32 |
| Fluoxetine Hcl | Fluoxetine Hcl | 120 | 31 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 116 | 35 |
| Tramadol Hcl | Tramadol Hcl | 114 | 40 |
| Metformin Hcl Er | Metformin Hcl | 101 | 32 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 99 | 26 |
| Ibuprofen | Ibuprofen | 97 | 32 |
| Doxycycline Hyclate | Doxycycline Hyclate | 94 | 65 |
| Buspirone Hcl | Buspirone Hcl | 93 | 25 |
| Trazodone Hcl | Trazodone Hcl | 93 | 29 |
| Ozempic | Semaglutide | 88 | 15 |
| Synthroid | Levothyroxine Sodium | 88 | 23 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 86 | 47 |
| Tizanidine Hcl | Tizanidine Hcl | 86 | 38 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 85 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 85 | 30 |
| Celecoxib | Celecoxib | 80 | 21 |
| Amoxicillin | Amoxicillin | 76 | 46 |
| Bupropion Xl | Bupropion Hcl | 76 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 74 | 22 |
| Allopurinol | Allopurinol | 72 | 19 |
| Duloxetine Hcl | Duloxetine Hcl | 71 | 18 |
| Januvia | Sitagliptin Phosphate | 71 | 21 |
| Finasteride | Finasteride | 69 | 19 |
| Raloxifene Hcl | Raloxifene Hcl | 67 | 17 |
| Estradiol | Estradiol | 66 | 17 |
| Glimepiride | Glimepiride | 66 | 22 |
| Ezetimibe | Ezetimibe | 65 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 61 | 19 |
| Valsartan | Valsartan | 60 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 55 | 17 |
| Donepezil Hcl | Donepezil Hcl | 54 | 14 |
| Mirtazapine | Mirtazapine | 53 | 15 |
| Famotidine | Famotidine | 49 | 16 |
| Spironolactone | Spironolactone | 49 | 14 |
| Clonazepam | Clonazepam | 48 | 11 |
| Lansoprazole | Lansoprazole | 48 | 17 |
| Myrbetriq | Mirabegron | 48 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 47 | 19 |
| Enalapril Maleate | Enalapril Maleate | 47 | 13 |
| Lorazepam | Lorazepam | 46 | 23 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 46 | 22 |
| Trulicity | Dulaglutide | 46 | suppressed |
| Carvedilol | Carvedilol | 44 | 15 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 44 | 15 |
| Valacyclovir | Valacyclovir Hcl | 44 | 30 |
| Methylprednisolone | Methylprednisolone | 43 | 41 |
| Ramipril | Ramipril | 43 | 12 |
| Methylphenidate Hcl | Methylphenidate Hcl | 42 | 13 |
| Levetiracetam | Levetiracetam | 41 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 41 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 40 | 11 |
| Nitroglycerin | Nitroglycerin | 40 | 22 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 40 | 26 |
| Aripiprazole | Aripiprazole | 39 | suppressed |
| Topiramate | Topiramate | 39 | 12 |
| Nifedipine Er | Nifedipine | 38 | suppressed |
| Xarelto | Rivaroxaban | 38 | 13 |
| Baclofen | Baclofen | 35 | suppressed |
| Torsemide | Torsemide | 35 | 11 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 34 | suppressed |
| Pregabalin | Pregabalin | 34 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 34 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 32 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 31 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 30 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 27 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 26 | suppressed |
| Fluconazole | Fluconazole | 26 | 21 |
| Nystatin | Nystatin | 25 | 15 |
| Oxycodone Hcl | Oxycodone Hcl | 25 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 24 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Premarin | Estrogens, Conjugated | 24 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 24 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 24 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 24 | suppressed |
| Cephalexin | Cephalexin | 23 | 19 |
| Dulera | Mometasone/Formoterol | 23 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 23 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 23 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 20 |
| Cefuroxime | Cefuroxime Axetil | 22 | 22 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 22 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 21 | suppressed |
| Azithromycin | Azithromycin | 21 | 13 |
| Eszopiclone | Eszopiclone | 21 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 21 | suppressed |
| Levofloxacin | Levofloxacin | 21 | 16 |
| Methadone Hcl | Methadone Hcl | 21 | suppressed |
| Risperidone | Risperidone | 21 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 20 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 20 | suppressed |
| Praluent Pen | Alirocumab | 20 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Lamictal | Lamotrigine | 19 | suppressed |
| Metronidazole | Metronidazole | 19 | 12 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 18 | suppressed |
| Levoxyl | Levothyroxine Sodium | 18 | suppressed |
| Pulmicort Flexhaler | Budesonide | 18 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 16 | suppressed |
| Diazepam | Diazepam | 16 | suppressed |
| Dutasteride | Dutasteride | 16 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 16 | suppressed |
| Metolazone | Metolazone | 16 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 16 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Zaleplon | Zaleplon | 15 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 14 | suppressed |
| Glipizide Er | Glipizide | 14 | suppressed |
| Jardiance | Empagliflozin | 14 | suppressed |
| Mirabegron Er | Mirabegron | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 14 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 14 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Loperamide | Loperamide Hcl | 13 | suppressed |
| Memantine Hcl | Memantine Hcl | 13 | suppressed |
| Naratriptan Hcl | Naratriptan Hcl | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Oxymorphone Hcl Er | Oxymorphone Hcl | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 12 | suppressed |
| Azathioprine | Azathioprine | 11 | suppressed |
| Benzonatate | Benzonatate | 11 | suppressed |
| Captopril | Captopril | 11 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 11 | suppressed |
| Estradiol (Twice Weekly) | Estradiol | 11 | suppressed |
| Estradiol-Norethindrone Acetat | Estradiol/Norethindrone Acet | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $32.77 · 2 records | Abbott Laboratories | EOHILIA, FREESTYLE LIBRE 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error